{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:10:24Z","timestamp":1793398224000,"version":"4.5.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>While emerging evidence supports a link between traumatic brain injury (TBI) and progressive cognitive dysfunction in Veterans, there is insufficient information on the impact of cannabis use disorder (CUD) on long-term cognitive disorders. This study aimed to examine the incidences of cognitive disorders in Veterans with TBI and CUD and to evaluate their relationship.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective cohort study used the US Department of Veterans Affairs and Department of Defense administrative data from the Long-term Impact of Military-Relevant Brain Injury Consortium-Chronic Effects of Neurotrauma Consortium Phenotype study. Diagnoses suggesting cognitive disorders after a TBI index date were identified using inpatient and outpatient data from 2003 to 2022. We compared the differential cognitive disorders incidence in Veterans who had the following: (1) no CUD or TBI (control group), (2) CUD only, (3) TBI only, and (4) comorbid CUD+TBI. Kaplan-Meier analyses were used to estimate the overall cognitive disorders incidence in the above study groups. The crude and adjusted Cox proportional hazards models were used to estimate crude and adjusted hazard ratios (HRs) for cognitive disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1,560,556 Veterans [82.32% male, median (IQR) age at the time of TBI, 34.51 (11.29) years, and 61.35% white] were evaluated. The cognitive disorder incidence rates were estimated as 0.68 (95% CI, 0.62, 0.75) for CUD only and 1.03 (95% CI, 1.00, 1.06) for TBI only per 10,000 person-months of observations, with the highest estimated cognitive disorder incidence observed in participants with both TBI and CUD [1.83 (95% CI, 1.72, 1.95)]. Relative to the control group, the highest hazard of cognitive disorders was observed in Veterans with CUD+TBI [hazard ratio (HR), 3.26; 95% CI, 2.91, 3.65], followed by those with TBI only (2.32; 95 CI%, 2.13, 2.53) and with CUD (1.79; 95 CI%, 1.60, 2.00). Of note, in the CUD only subgroup, we also observed the highest risk of an early onset cognitive disorder other than Alzheimer's disease and Frontotemporal dementia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The results of this analysis suggest that individuals with comorbid TBI and CUD may be at increased risk for early onset cognitive disorders, including dementia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1261249","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:37:59Z","timestamp":1705379879000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Cannabis use disorder contributes to cognitive dysfunction in Veterans with traumatic brain injury"],"prefix":"10.3389","volume":"15","author":[{"given":"Aryan","family":"Esmaeili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Dismuke-Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri K.","family":"Pogoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Amuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Del Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddy","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cifu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jamaneurol.2018.0815","article-title":"Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans","volume":"75","author":"Barnes","year":"2018","journal-title":"JAMA Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.31887\/DCNS.2019.21.3\/pharvey","article-title":"Domains of cognition and their assessment","volume":"21","author":"Harvey","year":"2019","journal-title":"Dialog Clin Neurosci."},{"key":"B3","unstructured":"Dementia mortality in the United States, 2000-2017129\n            KramarowEA\n            Tejada-VeraB\n          31112120Natl Vital Stat Rep.682019"},{"key":"B4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/WNL.0000000000000616","article-title":"Traumatic brain injury and risk of dementia in older veterans","volume":"83","author":"Barnes","year":"2014","journal-title":"Neurology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40779-021-00346-z","article-title":"Dementia in military and veteran populations: a review of risk factors-traumatic brain injury, post-traumatic stress disorder, deployment, and sleep","volume":"8","author":"Raza","year":"2021","journal-title":"Mil Med Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/00001199-200609000-00004","article-title":"Military TBI during the Iraq and Afghanistan wars","volume":"21","author":"Warden","year":"2006","journal-title":"J Head Trauma Rehabil."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.apmr.2020.07.005","article-title":"Recommendations for prescribing opioids for people with traumatic brain injury","volume":"101","author":"Trexler","year":"2020","journal-title":"Arch Phys Med Rehabil."},{"key":"B8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3233\/NRE-2010-0556","article-title":"Hospitalization associated with traumatic brain injury in the active duty US Army: 2000-2006","volume":"26","author":"Ivins","year":"2010","journal-title":"NeuroRehabilitation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.psc.2010.08.007","article-title":"Combat-related traumatic brain injury and its implications to military healthcare","volume":"33","author":"Meyer","year":"2010","journal-title":"Psychiatr Clin North Am."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00001199-199510030-00002","article-title":"Persistent postconcussion syndrome: The structure of subjective complaints after mild traumatic brain injury","volume":"10","author":"Cicerone","year":"1995","journal-title":"J Head Trauma Rehabil."},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/HTR.0b013e318230fb17","article-title":"Psychometric assessment of the neurobehavioral symptom inventory-22: the structure of persistent postconcussive symptoms following deployment-related mild traumatic brain injury among veterans","volume":"27","author":"Meterko","year":"2012","journal-title":"J Head Trauma Rehabil."},{"key":"B12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/02699052.2022.2033843","article-title":"Clinical research findings from the long-term impact of military-relevant brain injury consortium-chronic effects of neurotrauma consortium (LIMBIC-CENC) 2013-2021","volume":"36","author":"Cifu","year":"2022","journal-title":"Brain Inj."},{"key":"B13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.expneurol.2015.06.015","article-title":"Polypathology and dementia after brain trauma: Does brain injury trigger distinct neurodegenerative diseases, or should they be classified together as traumatic encephalopathy?","author":"Washington","year":"2016","journal-title":"Exp Neurol 275 Pt 3"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/jnnp-2017-317557","article-title":"Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia","volume":"90","author":"Graham","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a009724","article-title":"Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study","volume":"149","author":"Nemetz","year":"1999","journal-title":"Am J Epidemiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1080\/02699052.2022.2033846","article-title":"Traumatic brain injury and early onset dementia in post 9-11 veterans","volume":"36","author":"Kennedy","year":"2022","journal-title":"Brain Inj."},{"key":"B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fpubh.2013.00042","article-title":"Marijuana: current concepts(dagger)","volume":"1","author":"Greydanus","year":"2013","journal-title":"Front Public Health."},{"key":"B18","year":"2023","journal-title":"FDA and Cannabis: Research and Drug Approval Process"},{"key":"B19","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5).","author":"American","year":"2013"},{"key":"B20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11920-013-0419-7","article-title":"Medical consequences of marijuana use: a review of current literature","volume":"15","author":"Gordon","year":"2013","journal-title":"Curr Psychiatry Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11481-018-9782-9","article-title":"Cannabis addiction and the brain: a review","volume":"13","author":"Zehra","year":"2018","journal-title":"J Neuroimmune Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/can.2016.0007","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/cjn.2019.298","article-title":"Cannabis in the treatment of traumatic brain injury: a primer for clinicians","volume":"47","author":"Grenier","year":"2020","journal-title":"Can J Neurol Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1089\/neu.2020.7148","article-title":"Use of medical cannabis to treat traumatic brain injury","volume":"38","author":"Hergert","year":"2021","journal-title":"J Neurotrauma."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e2158","DOI":"10.1093\/milmed\/usac011","article-title":"Cannabis use in a cohort of healthcare-seeking united states military veterans with persisting symptoms after mild traumatic brain injury: preliminary observations","volume":"188","author":"Utter","year":"2022","journal-title":"Mil Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ypmed.2017.07.008","article-title":"Cannabis use attitudes, and legal status in the US: A review","volume":"104","author":"Carliner","year":"2017","journal-title":"Prev Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.apmr.2018.02.003","article-title":"Cannabis use in individuals with spinal cord injury or moderate to severe traumatic brain injury in Colorado","volume":"99","author":"Hawley","year":"2018","journal-title":"Arch Phys Med Rehabil."},{"key":"B28","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S2215-0366(16)30208-5","article-title":"Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys","volume":"3","author":"Compton","year":"2016","journal-title":"Lancet Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"106963","DOI":"10.1016\/j.addbeh.2021.106963","article-title":"Prevalence of cannabis use, disorder, and medical card possession in US military veterans: results from the 2019\u20132020 national health and resilience in veterans study","volume":"120","author":"Hill","year":"2021","journal-title":"Addict Behav."},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1176\/appi.ajp.2021.20081202","article-title":"Prevalence and correlates of cannabis use and cannabis use disorder among US veterans: results from the national epidemiologic survey on alcohol and related conditions (NESARC-III)","volume":"179","author":"Browne","year":"2022","journal-title":"Am J Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.22010034","article-title":"Trends in cannabis use disorder diagnoses in the US veterans health administration, 2005\u20132019","volume":"179","author":"Hasin","year":"2022","journal-title":"Am J Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1080\/10826084.2023.2191700","article-title":"National trends in past-year Marijuana use among veterans in the United States, 2013-2019","volume":"58","author":"Yockey","year":"2023","journal-title":"Subst Use Misuse."},{"key":"B33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1021\/mp060066m","article-title":"A molecular link between the active component of marijuana and Alzheimer's disease pathology","volume":"3","author":"Eubanks","year":"2006","journal-title":"Mol Pharm."},{"key":"B34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000498924","article-title":"Prescription of a THC\/CBD-based medication to patients with dementia: a pilot study in Geneva","volume":"2","author":"Broers","year":"2019","journal-title":"Med Cannabis Cannabinoids."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2042098619846993","DOI":"10.1177\/2042098619846993","article-title":"Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review","volume":"10","author":"Hillen","year":"2019","journal-title":"Ther Adv Drug Saf."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007204.pub2","article-title":"Cannabinoids for the treatment of dementia","author":"Krishnan","year":"2009","journal-title":"Cochr Datab Syst Rev"},{"key":"B37","volume-title":"Medical Cannabis for the Treatment of Dementia: A Review of Clinical Effectiveness and Guidelines","author":"Peprah","year":"2019"},{"key":"B38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neubiorev.2021.01.003","article-title":"Determining the magnitude and duration of acute Delta(9)-tetrahydrocannabinol (Delta(9)-THC)-induced driving and cognitive impairment: a systematic and meta-analytic review","volume":"126","author":"McCartney","year":"2021","journal-title":"Neurosci Biobehav Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41583-021-00466-4","article-title":"The why behind the high: determinants of neurocognition during acute cannabis exposure","volume":"22","author":"Ramaekers","year":"2021","journal-title":"Nat Rev Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1001\/archpsyc.65.6.694","article-title":"Regional brain abnormalities associated with long-term heavy cannabis use","volume":"65","author":"Yucel","year":"2008","journal-title":"Arch Gen Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jpsychires.2011.01.004","article-title":"Medial temporal structures and memory functions in adolescents with heavy cannabis use","volume":"45","author":"Ashtari","year":"2011","journal-title":"J Psychiatr Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2010.09.020","article-title":"Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol","volume":"114","author":"Demirakca","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"B43","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/adb.12027","article-title":"Modulation of brain structure by catechol-O-methyltransferase Val158Met polymorphism in chronic cannabis users","volume":"19","author":"Batalla","year":"2014","journal-title":"Addict Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"16913","DOI":"10.1073\/pnas.1415297111","article-title":"Long-term effects of marijuana use on the brain","volume":"111","author":"Filbey","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1176\/appi.ajp.2021.21060664","article-title":"Long-term cannabis use and cognitive reserves and hippocampal volume in midlife","volume":"179","author":"Meier","year":"2022","journal-title":"Am J Psychiatr."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jamaneurol.2022.2682","article-title":"Association between traumatic brain injury and subsequent cardiovascular disease among post-9\/11-era veterans","volume":"79","author":"Stewart","year":"2022","journal-title":"JAMA Neurol."},{"key":"B47","volume-title":"Armed Forces Health Surveillance Branch","year":"2019"},{"key":"B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000358050","article-title":"Inadequate diagnostic evaluation in young patients registered with a diagnosis of dementia: a nationwide register-based study","volume":"4","author":"Salem","year":"2014","journal-title":"Dement Geriatr Cogn Dis Extra."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/13854046.2019.1679889","article-title":"Validity of early-onset dementia diagnoses in VA electronic medical record administrative data","volume":"34","author":"Marceaux","year":"2020","journal-title":"Clin Neuropsychol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jalz.2017.04.010","article-title":"Head or brain injuries and Alzheimer's disease: a nested case-control register study","volume":"13","author":"Tolppanen","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/jnnp-2012-302633","article-title":"Population based study on patients with traumatic brain injury suggests increased risk of dementia","volume":"83","author":"Wang","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B52","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3233\/JAD-161002","article-title":"What is the relationship of traumatic brain injury to dementia?","volume":"57","author":"Mendez","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00068-004-1394-9","article-title":"The role of neuroinflammation in traumatic brain injury","volume":"30","author":"Schmidt","year":"2004","journal-title":"Eur J Trauma."},{"key":"B54","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","article-title":"Traumatic brain injuries: pathophysiology and potential therapeutic targets","volume":"13","author":"Ng","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00001199-200307000-00003","article-title":"Diffuse axonal injury in head trauma","volume":"18","author":"Smith","year":"2003","journal-title":"J Head Trauma Rehabil."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030265","article-title":"Cannabinoids, blood-brain barrier, and brain disposition","author":"Calapai","year":"2020","journal-title":"Pharmaceutics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1037\/1064-1297.14.4.422","article-title":"Altered regional blood volume in chronic cannabis smokers","volume":"14","author":"Sneider","year":"2006","journal-title":"Exp Clin Psychopharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41386-021-01226-9","article-title":"Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants","volume":"47","author":"Lichenstein","year":"2022","journal-title":"Neuropsychopharmacology."},{"key":"B59","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol Aging."},{"key":"B60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.addbeh.2017.03.006","article-title":"Cannabis use patterns and motives: a comparison of younger, middle-aged, and older medical cannabis dispensary patients","volume":"72","author":"Haug","year":"2017","journal-title":"Addict Behav."},{"key":"B61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s42238-019-0006-9","article-title":"Age related differences in cannabis use and subjective effects in a large population-based survey of adult athletes","volume":"1","author":"Zeiger","year":"2019","journal-title":"J Cannabis Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.1038\/s41598-019-44848-2","article-title":"Genetic analyses of early-onset Alzheimer's disease using next generation sequencing","volume":"9","author":"Giau","year":"2019","journal-title":"Sci Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","article-title":"Dopamine and dopamine receptors in Alzheimer's disease: a systematic review and network meta-analysis","volume":"11","author":"Pan","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"103852","DOI":"10.1016\/j.mcn.2023.103852","article-title":"Pleiotropic loci for cannabis use disorder severity in multi-ancestry high-risk populations","volume":"125","author":"Peng","year":"2023","journal-title":"Mol Cell Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1101\/cshperspect.a012229","article-title":"A brain on cannabinoids: the role of dopamine release in reward seeking","volume":"2","author":"Oleson","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1242\/dmm.011585","article-title":"The pathophysiology of traumatic brain injury at a glance","volume":"6","author":"Prins","year":"2013","journal-title":"Dis Model Mech."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B68","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/j.mce.2008.02.003","article-title":"Long lasting consequences of cannabis exposure in adolescence","volume":"286","author":"Rubino","year":"2008","journal-title":"Mol Cell Endocrinol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/ejp.1377","article-title":"Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders","volume":"23","author":"Krebs","year":"2019","journal-title":"Eur J Pain."},{"key":"B70","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00213-012-2674-4","article-title":"Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users","volume":"222","author":"Jacobus","year":"2012","journal-title":"Psychopharmacology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"108129","DOI":"10.1016\/j.drugalcdep.2020.108129","article-title":"and CBD blood and brain concentrations following daily administration to adolescent primates","volume":"213","author":"Withey","year":"2020","journal-title":"Drug Alcohol Depend."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1261249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T04:38:05Z","timestamp":1705379885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1261249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":71,"alternative-id":["10.3389\/fneur.2024.1261249"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1261249","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"article-number":"1261249"}}